This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock LLIT vs. TELA, CTSO, DXR, MODD, TMDIF, MDAI, HSAQ, NMTC, DRIO, and PYPDShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include TELA Bio (TELA), Cytosorbents (CTSO), Daxor (DXR), Modular Medical (MODD), Titan Medical (TMDIF), Spectral AI (MDAI), Health Sciences Acquisitions Co. 2 (HSAQ), NeuroOne Medical Technologies (NMTC), DarioHealth (DRIO), and PolyPid (PYPD). These companies are all part of the "medical" sector. Lianluo Smart vs. TELA Bio Cytosorbents Daxor Modular Medical Titan Medical Spectral AI Health Sciences Acquisitions Co. 2 NeuroOne Medical Technologies DarioHealth PolyPid Lianluo Smart (NASDAQ:LLIT) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations. Do analysts recommend LLIT or TELA? TELA Bio has a consensus price target of $7.25, indicating a potential upside of 403.47%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts plainly believe TELA Bio is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders & institutionals believe in LLIT or TELA? 28.8% of Lianluo Smart shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 22.9% of Lianluo Smart shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, LLIT or TELA? Lianluo Smart has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Is LLIT or TELA more profitable? Lianluo Smart has a net margin of 0.00% compared to TELA Bio's net margin of -60.49%. Lianluo Smart's return on equity of 0.00% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A TELA Bio -60.49%-556.18%-63.13% Does the media favor LLIT or TELA? In the previous week, TELA Bio had 2 more articles in the media than Lianluo Smart. MarketBeat recorded 2 mentions for TELA Bio and 0 mentions for Lianluo Smart. Lianluo Smart's average media sentiment score of 0.00 equaled TELA Bio'saverage media sentiment score. Company Overall Sentiment Lianluo Smart Neutral TELA Bio Neutral Which has stronger earnings & valuation, LLIT or TELA? Lianluo Smart has higher earnings, but lower revenue than TELA Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K32.32-$4.45MN/AN/ATELA Bio$71.22M0.80-$46.66M-$1.41-1.02 Does the MarketBeat Community favor LLIT or TELA? Lianluo Smart received 44 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.07% of users gave TELA Bio an outperform vote while only 70.27% of users gave Lianluo Smart an outperform vote. CompanyUnderperformOutperformLianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% TELA BioOutperform Votes6074.07% Underperform Votes2125.93% SummaryTELA Bio beats Lianluo Smart on 8 of the 15 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.28M$4.44B$5.33B$8.31BDividend YieldN/A45.13%5.27%4.10%P/E RatioN/A29.9426.8119.58Price / Sales32.3269.03396.30135.12Price / CashN/A51.0838.3234.62Price / Book-9.426.186.764.50Net Income-$4.45M$68.15M$3.24B$248.56M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$5.56-0.4%N/A+411.9%$12.28M$380,000.000.006Gap DownTELATELA Bio1.8423 of 5 stars$1.33+15.7%$7.25+445.1%-75.6%$52.61M$71.22M-0.79120News CoverageCTSOCytosorbents2.1779 of 5 stars$0.84-1.2%$5.50+554.6%-9.5%$52.61M$35.59M-2.33220News CoverageAnalyst ForecastGap UpDXRDaxor3.7845 of 5 stars$7.60-1.0%$25.00+228.9%-19.4%$36.76M$2.13M0.0037Gap UpMODDModular Medical0.8597 of 5 stars$0.89-9.4%N/A-44.6%$36.09MN/A-1.6720News CoverageGap DownTMDIFTitan MedicalN/A$0.31-0.1%N/A+858.4%$34.78M$17.63M-0.2450Gap DownMDAISpectral AI3.0554 of 5 stars$1.36+0.7%$4.75+249.3%-10.4%$34.43M$29.58M-2.0983News CoverageAnalyst UpgradeAnalyst RevisionHSAQHealth Sciences Acquisitions Co. 2N/A$2.92+0.7%N/A-47.5%$32.74MN/A0.004Gap DownNMTCNeuroOne Medical Technologies1.8761 of 5 stars$0.62-6.0%$1.45+133.3%-42.9%$30.97M$5.75M-2.3920Negative NewsDRIODarioHealth1.8591 of 5 stars$0.69+4.5%$2.00+189.9%-55.0%$30.33M$27.04M-0.73200Analyst DowngradePYPDPolyPid1.5707 of 5 stars$2.90+3.2%$11.33+290.8%-35.7%$29.55MN/A-0.5880High Trading Volume Related Companies and Tools Related Companies TELA Bio Competitors Cytosorbents Competitors Daxor Competitors Modular Medical Competitors Titan Medical Competitors Spectral AI Competitors Health Sciences Acquisitions Co. 2 Competitors NeuroOne Medical Technologies Competitors DarioHealth Competitors PolyPid Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LLIT Stock Free LLIT Stock Alerts